v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Units

Pursuant to the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the Company initiated grants of restricted stock units (“RSUs”) to certain employees as follows:

  

   Three Months Ended March 31, 
   2026   2025 
   Number of RSUs   Weighted Average Fair Value  

Number of RSUs

   Weighted Average Fair Value 
Outstanding as of Beginning of Period   831,346   $2.32       $ 
Granted   437,431    4.63    852,214    2.31 
Vested   (3,334)   2.36         
Outstanding as of End of Period   1,265,443   $3.12    852,214   $2.31 
Schedule of Stock Option Activity

The following is a summary of the Company’s outstanding stock options as of March 31, 2026 and December 31, 2025:

 

   Number of Options   Weighted Avg. Remaining Contractual Life (in years)   Weighted Avg. Exercise Price   Aggregate Intrinsic Value 
Outstanding as of December 31, 2025   1,319,394    3.69   $6.94   $ 
Outstanding as of March 31, 2026   1,319,394    3.44   $6.94   $ 
Vested and Exercisable as of March 31, 2026   1,319,394    3.44   $6.94   $